Skip to content
LexBuild

National Institute of Biomedical Imaging and Bioengineering; Notice of Closed Meeting

---
identifier: "/us/fr/07-238"
source: "fr"
legal_status: "authoritative_unofficial"
title: "National Institute of Biomedical Imaging and Bioengineering; Notice of Closed Meeting"
title_number: 0
title_name: "Federal Register"
section_number: "07-238"
section_name: "National Institute of Biomedical Imaging and Bioengineering; Notice of Closed Meeting"
positive_law: false
currency: "2007-01-22"
last_updated: "2007-01-22"
format_version: "1.1.0"
generator: "[email protected]"
agency: "Health and Human Services Department"
document_number: "07-238"
document_type: "notice"
publication_date: "2007-01-22"
agencies:
  - "Health and Human Services Department"
  - "National Institutes of Health"
fr_citation: "72 FR 2703"
fr_volume: 72
---

#  National Institute of Biomedical Imaging and Bioengineering; Notice of Closed Meeting

Pursuant to section 10(d) of the Federal Advisory Committee act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting.

The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

*Name of Committee:* National Institute of Biomedical Imaging and Bioengineering Special Emphasis Panel, ZEB1 OSR-D M1 Training Grants Review.

*Date:* February 27, 2007.

*Time:* 8 a.m. to 5 p.m.

*Agenda:* To review and evaluate grant applications.

*Place:* Double Tree Hotel Rockville, 1750 Rockville Pike, Rockville, MD 20852.

*Contact Person:* John Hayes, Scientific Review Administrator, 6707 Democracy Blvd., Suite 959, Democracy Two, Bethesda, MD 20892, (301) 451-3398, *[email protected]* .

Dated: January 12, 2007.

David Clary,

Acting Director, Office of Federal Advisory Committee Policy.